Annual FCF
$1.93 M
+$4.01 M+192.63%
December 31, 2021
Summary
- As of February 10, 2025, OPNT annual free cash flow is $1.93 million, with the most recent change of +$4.01 million (+192.63%) on December 31, 2021.
- During the last 3 years, OPNT annual FCF has risen by +$2.45 million (+468.36%).
Performance
OPNT Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly FCF
-$5.15 M
+$5.48 M+51.55%
September 30, 2022
Summary
- As of February 10, 2025, OPNT quarterly free cash flow is -$5.15 million, with the most recent change of +$5.48 million (+51.55%) on September 30, 2022.
- Over the past year, OPNT quarterly FCF has dropped by -$5.44 million (-1898.67%).
Performance
OPNT Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM FCF
-$15.88 M
-$5.44 M-52.05%
September 30, 2022
Summary
- As of February 10, 2025, OPNT TTM free cash flow is -$15.88 million, with the most recent change of -$5.44 million (-52.05%) on September 30, 2022.
- Over the past year, OPNT TTM FCF has dropped by -$14.17 million (-828.53%).
Performance
OPNT TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
OPNT Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +192.6% | -1898.7% | -828.5% |
| 3 y3 years | +468.4% | -433.7% | -522.3% |
| 5 y5 years | +150.2% | -431.1% | -522.3% |
OPNT Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -357.1% | +106.4% | -924.5% | at low |
| 5 y | 5-year | -48.8% | -208.0% | -175.1% | +106.4% | -347.7% | at low |
| alltime | all time | -65.3% | -320.0% | -143.3% | +106.4% | -243.8% | at low |
Opiant Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$5.15 M(-51.6%) | -$15.88 M(+52.1%) |
| Jun 2022 | - | -$10.63 M(+405.5%) | -$10.45 M(+453.0%) |
| Mar 2022 | - | -$2.10 M(-205.0%) | -$1.89 M(-198.1%) |
| Dec 2021 | $1.93 M(-192.6%) | $2.00 M(+599.6%) | $1.93 M(-212.6%) |
| Sep 2021 | - | $286.40 K(-113.8%) | -$1.71 M(+8.6%) |
| Jun 2021 | - | -$2.08 M(-221.2%) | -$1.58 M(+31.6%) |
| Mar 2021 | - | $1.71 M(-204.8%) | -$1.20 M(-42.4%) |
| Dec 2020 | -$2.08 M(-155.3%) | -$1.63 M(-487.5%) | -$2.08 M(-132.4%) |
| Sep 2020 | - | $421.60 K(-124.8%) | $6.41 M(+27.6%) |
| Jun 2020 | - | -$1.70 M(-304.5%) | $5.03 M(-16.8%) |
| Mar 2020 | - | $830.00 K(-87.9%) | $6.04 M(+60.5%) |
| Dec 2019 | $3.76 M(-819.2%) | $6.86 M(-810.5%) | $3.76 M(-213.5%) |
| Sep 2019 | - | -$965.30 K(+40.9%) | -$3.31 M(-0.5%) |
| Jun 2019 | - | -$685.10 K(-52.6%) | -$3.33 M(-20.1%) |
| Mar 2019 | - | -$1.45 M(+563.5%) | -$4.17 M(+697.2%) |
| Dec 2018 | -$523.00 K(-86.4%) | -$218.00 K(-77.8%) | -$523.00 K(+71.5%) |
| Sep 2018 | - | -$983.00 K(-35.4%) | -$305.00 K(+4.5%) |
| Jun 2018 | - | -$1.52 M(-169.2%) | -$292.00 K(-81.5%) |
| Mar 2018 | - | $2.20 M(-326.8%) | -$1.58 M(-132.3%) |
| Dec 2017 | -$3.84 M(-169.1%) | - | - |
| Oct 2017 | - | -$970.00 K(-65.5%) | $4.88 M(-12.1%) |
| Jul 2017 | $5.56 M(-702.1%) | -$2.81 M(-13.5%) | $5.56 M(-17.3%) |
| Apr 2017 | - | -$3.25 M(-127.3%) | $6.72 M(-39.2%) |
| Jan 2017 | - | $11.91 M(-4122.1%) | $11.04 M(-2446.0%) |
| Oct 2016 | - | -$296.00 K(-82.0%) | -$470.70 K(-49.0%) |
| Jul 2016 | -$922.80 K(-78.2%) | -$1.65 M(-252.4%) | -$922.90 K(+115.0%) |
| Apr 2016 | - | $1.08 M(+176.0%) | -$429.30 K(-80.7%) |
| Jan 2016 | - | $392.00 K(-152.4%) | -$2.22 M(-44.7%) |
| Oct 2015 | - | -$748.20 K(-35.2%) | -$4.01 M(-5.3%) |
| Jul 2015 | -$4.24 M | -$1.16 M(+62.7%) | -$4.24 M(+24.0%) |
| Apr 2015 | - | -$709.70 K(-49.3%) | -$3.42 M(+15.9%) |
| Jan 2015 | - | -$1.40 M(+43.8%) | -$2.95 M(+73.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Oct 2014 | - | -$974.00 K(+191.6%) | -$1.70 M(+69.5%) |
| Jul 2014 | -$1.01 M(+34.5%) | -$334.00 K(+39.4%) | -$1.01 M(-122.9%) |
| Apr 2014 | - | -$239.60 K(+52.8%) | $4.39 M(-644.5%) |
| Jan 2014 | - | -$156.80 K(-43.0%) | -$806.10 K(-1.3%) |
| Oct 2013 | - | -$274.90 K(-105.4%) | -$816.50 K(+9.3%) |
| Jul 2013 | -$747.30 K(-31.9%) | $5.06 M(-193.1%) | -$747.30 K(-87.9%) |
| Apr 2013 | - | -$5.43 M(+3150.4%) | -$6.16 M(+588.4%) |
| Jan 2013 | - | -$167.20 K(-18.7%) | -$894.30 K(+14.7%) |
| Oct 2012 | - | -$205.70 K(-41.1%) | -$779.50 K(-28.9%) |
| Jul 2012 | -$1.10 M(-62.9%) | -$349.00 K(+102.4%) | -$1.10 M(+26.5%) |
| Apr 2012 | - | -$172.40 K(+229.0%) | -$867.20 K(-71.2%) |
| Jan 2012 | - | -$52.40 K(-90.0%) | -$3.01 M(-8.4%) |
| Oct 2011 | - | -$522.90 K(+337.6%) | -$3.29 M(+11.2%) |
| Jul 2011 | -$2.96 M(+680.7%) | -$119.50 K(-94.8%) | -$2.96 M(+2.5%) |
| Apr 2011 | - | -$2.31 M(+602.1%) | -$2.88 M(+291.4%) |
| Jan 2011 | - | -$329.70 K(+71.7%) | -$736.60 K(+29.0%) |
| Oct 2010 | - | -$192.00 K(+310.3%) | -$571.00 K(+50.8%) |
| Jul 2010 | -$378.60 K(<-9900.0%) | -$46.80 K(-72.2%) | -$378.60 K(+14.2%) |
| Apr 2010 | - | -$168.10 K(+2.4%) | -$331.50 K(+102.8%) |
| Jan 2010 | - | -$164.10 K(<-9900.0%) | -$163.50 K(<-9900.0%) |
| Oct 2009 | - | $400.00(+33.3%) | $700.00(+600.0%) |
| Jul 2009 | $100.00(-200.0%) | $300.00(-400.0%) | $100.00(-99.1%) |
| Apr 2009 | - | -$100.00(-200.0%) | $10.60 K(+12.8%) |
| Jan 2009 | - | $100.00(-150.0%) | $9400.00(>+9900.0%) |
| Oct 2008 | - | -$200.00(-101.9%) | $0.00(0.0%) |
| Jul 2008 | -$100.00(-99.7%) | $10.80 K(-930.8%) | $0.00(-100.0%) |
| Apr 2008 | - | -$1300.00(-86.0%) | -$14.50 K(-38.8%) |
| Jan 2008 | - | -$9300.00(+4550.0%) | -$23.70 K(+5.3%) |
| Oct 2007 | - | -$200.00(-94.6%) | -$22.50 K(-26.7%) |
| Jul 2007 | -$30.60 K | -$3700.00(-64.8%) | -$30.70 K(+13.7%) |
| Apr 2007 | - | -$10.50 K(+29.6%) | -$27.00 K(+63.6%) |
| Jan 2007 | - | -$8100.00(-3.6%) | -$16.50 K(+96.4%) |
| Oct 2006 | - | -$8400.00 | -$8400.00 |
FAQ
- What is Opiant Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Opiant Pharmaceuticals?
- What is Opiant Pharmaceuticals annual FCF year-on-year change?
- What is Opiant Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Opiant Pharmaceuticals?
- What is Opiant Pharmaceuticals quarterly FCF year-on-year change?
- What is Opiant Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Opiant Pharmaceuticals?
- What is Opiant Pharmaceuticals TTM FCF year-on-year change?
What is Opiant Pharmaceuticals annual free cash flow?
The current annual FCF of OPNT is $1.93 M
What is the all time high annual FCF for Opiant Pharmaceuticals?
Opiant Pharmaceuticals all-time high annual free cash flow is $5.56 M
What is Opiant Pharmaceuticals annual FCF year-on-year change?
Over the past year, OPNT annual free cash flow has changed by +$4.01 M (+192.63%)
What is Opiant Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of OPNT is -$5.15 M
What is the all time high quarterly FCF for Opiant Pharmaceuticals?
Opiant Pharmaceuticals all-time high quarterly free cash flow is $11.91 M
What is Opiant Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, OPNT quarterly free cash flow has changed by -$5.44 M (-1898.67%)
What is Opiant Pharmaceuticals TTM free cash flow?
The current TTM FCF of OPNT is -$15.88 M
What is the all time high TTM FCF for Opiant Pharmaceuticals?
Opiant Pharmaceuticals all-time high TTM free cash flow is $11.04 M
What is Opiant Pharmaceuticals TTM FCF year-on-year change?
Over the past year, OPNT TTM free cash flow has changed by -$14.17 M (-828.53%)